Doxycycline treatment of otosyphilis with hearing loss

Sex Transm Infect. 2012 Apr;88(3):177-8. doi: 10.1136/sextrans-2011-050201. Epub 2012 Jan 27.

Abstract

Objectives: The recommended treatment of otosyphilis is intravenous penicillin therapy. The response rate varied between 23% and 31%. This treatment needs hospitalisation and is costly, inconvenient and time consuming. Oral doxycycline was tested for its efficacy in otosyphilis.

Method: The authors reviewed 19 patients diagnosed as having otosyphilis with hearing loss at the outpatient unit between 2004 and 2008 by oral doxycycline 400 mg/day for 21 days.

Results: Of those enrolled patients, 12 patients were male and the mean age is 69.4 years. The hearing was improved in nine patients (47.3%) and the audiogram of seven patients (36.8%) showed improvement. There was no serious side effect of doxycycline.

Conclusion: The data suggest that doxycycline may be an effective alternate regimen for otosyphilis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / administration & dosage*
  • Doxycycline / administration & dosage*
  • Female
  • Hearing Loss / drug therapy*
  • Hearing Loss / prevention & control
  • Hearing Tests
  • Humans
  • Male
  • Middle Aged
  • Otitis / complications*
  • Otitis / drug therapy*
  • Syphilis / complications*
  • Syphilis / drug therapy*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Doxycycline